ArticleFrontiers in medicine2026
Structural anterior segment OCT biomarkers do not predict secondary intervention after Preserflo MicroShunt implantation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Purpose: This study aimed to evaluate the anterior segment optical coherence tomography (AS-OCT) parameters bleb wall thickness (BWT) and total bleb height (TBH) in the early postoperative phase after Preserflo MicroShunt (PM) implantation for their correlation with (a) secondary interventions and (b) AS-OCT angiography (AS-OCTA)-derived bleb vessel density (BVD). Materials and methods: In a prospective longitudinal study of 23 open-angle glaucoma patients, AS-OCT measurements of BWT and TBH and AS-OCTA measurements of BVD were obtained at 1, 2, and 4 weeks (1 W, 2 W, and 4 W), as well as at 2, 3, 6, 9, and 12 months postoperatively. Secondary interventions (needling or open revision) were recorded. The correlations of BWT and TBH with (a) secondary interventions and (b) BVD were assessed. Results: A total of 10 of 23 patients needed secondary interventions between 4 and 48 weeks after PM implantation. At 1, 2, and 4 weeks after surgery, neither BWT nor TBH was significantly associated with future secondary interventions (BWT/TBH Conclusion: Structural AS-OCT-based bleb thickness parameters (BWT and TBH) in the early postoperative phase were not significantly associated with future secondary interventions after PM implantation and did not correlate with AS-OCTA-derived BVD. BVD, which was shown to be a viable biomarker for future secondary interventions in a previous analysis of the same cohort, could be a better predictor of secondary interventions after PM implantation than BWT/TBH. Larger studies are necessary to confirm these hypothesis-generating findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.